scPharmaceuticals (NASDAQ:SCPH) Earns “Buy” Rating from HC Wainwright
scPharmaceuticals (NASDAQ:SCPH – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report released on Thursday,Benzinga reports. They currently have a $18.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 427.86% from the stock’s previous close. Separately, Craig Hallum […]
More Stories
WisdomTree China ex-State-Owned Enterprises Fund (NASDAQ:CXSE) Short Interest Update
WisdomTree China ex-State-Owned Enterprises Fund (NASDAQ:CXSE – Get Free Report) was the target of a significant drop in short interest...
Taysha Gene Therapies’ (TSHA) Buy Rating Reiterated at Chardan Capital
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Chardan Capital...
Allogene Therapeutics (NASDAQ:ALLO) Given Outperform Rating at William Blair
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at William Blair in...
Koppers Holdings Inc. (NYSE:KOP) CEO M Leroy Ball Sells 5,000 Shares
Koppers Holdings Inc. (NYSE:KOP – Get Free Report) CEO M Leroy Ball sold 5,000 shares of the firm’s stock in...
Pediatrix Medical Group, Inc. (NYSE:MD) Director Sells $423,660.00 in Stock
Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) Director Mark S. Ordan sold 27,600 shares of the company’s stock...
WK Kellogg Co (NYSE:KLG) Director Purchases $1,154,400.00 in Stock
WK Kellogg Co (NYSE:KLG – Get Free Report) Director G Zachary Gund bought 65,000 shares of the stock in a...